NM_004656.4:c.1729+8T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004656.4(BAP1):​c.1729+8T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00626 in 1,613,504 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0036 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0065 ( 52 hom. )

Consequence

BAP1
NM_004656.4 splice_region, intron

Scores

2
Splicing: ADA: 0.0001674
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:22

Conservation

PhyloP100: -0.160

Publications

4 publications found
Variant links:
Genes affected
BAP1 (HGNC:950): (BRCA1 associated protein 1) This gene belongs to the ubiquitin C-terminal hydrolase subfamily of deubiquitinating enzymes that are involved in the removal of ubiquitin from proteins. The encoded enzyme binds to the breast cancer type 1 susceptibility protein (BRCA1) via the RING finger domain of the latter and acts as a tumor suppressor. In addition, the enzyme may be involved in regulation of transcription, regulation of cell cycle and growth, response to DNA damage and chromatin dynamics. Germline mutations in this gene may be associated with tumor predisposition syndrome (TPDS), which involves increased risk of cancers including malignant mesothelioma, uveal melanoma and cutaneous melanoma. [provided by RefSeq, May 2013]
BAP1 Gene-Disease associations (from GenCC):
  • BAP1-related tumor predisposition syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • Kury-Isidor syndrome
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P
  • renal cell carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-52403408-A-G is Benign according to our data. Variant chr3-52403408-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 240050.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00363 (553/152300) while in subpopulation NFE AF = 0.00671 (456/68004). AF 95% confidence interval is 0.0062. There are 2 homozygotes in GnomAd4. There are 245 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 553 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004656.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BAP1
NM_004656.4
MANE Select
c.1729+8T>C
splice_region intron
N/ANP_004647.1Q92560
BAP1
NM_001410772.1
c.1675+8T>C
splice_region intron
N/ANP_001397701.1F8W6N3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BAP1
ENST00000460680.6
TSL:1 MANE Select
c.1729+8T>C
splice_region intron
N/AENSP00000417132.1Q92560
BAP1
ENST00000478368.1
TSL:1
c.232+8T>C
splice_region intron
N/AENSP00000420647.1H0Y8E8
BAP1
ENST00000469613.5
TSL:1
c.117+393T>C
intron
N/AENSP00000418320.1H7C4V7

Frequencies

GnomAD3 genomes
AF:
0.00363
AC:
553
AN:
152182
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00140
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00670
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00347
AC:
868
AN:
250326
AF XY:
0.00375
show subpopulations
Gnomad AFR exome
AF:
0.00136
Gnomad AMR exome
AF:
0.000839
Gnomad ASJ exome
AF:
0.000697
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000704
Gnomad NFE exome
AF:
0.00601
Gnomad OTH exome
AF:
0.00327
GnomAD4 exome
AF:
0.00654
AC:
9554
AN:
1461204
Hom.:
52
Cov.:
32
AF XY:
0.00649
AC XY:
4721
AN XY:
726882
show subpopulations
African (AFR)
AF:
0.000717
AC:
24
AN:
33472
American (AMR)
AF:
0.000850
AC:
38
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000804
AC:
21
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00336
AC:
290
AN:
86256
European-Finnish (FIN)
AF:
0.000643
AC:
34
AN:
52904
Middle Eastern (MID)
AF:
0.00312
AC:
18
AN:
5768
European-Non Finnish (NFE)
AF:
0.00795
AC:
8836
AN:
1111870
Other (OTH)
AF:
0.00484
AC:
292
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
630
1261
1891
2522
3152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
356
712
1068
1424
1780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00363
AC:
553
AN:
152300
Hom.:
2
Cov.:
33
AF XY:
0.00329
AC XY:
245
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00140
AC:
58
AN:
41558
American (AMR)
AF:
0.00131
AC:
20
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4832
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00671
AC:
456
AN:
68004
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
30
60
91
121
151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00466
Hom.:
1
Bravo
AF:
0.00338
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00731
EpiControl
AF:
0.00658

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
5
not provided (5)
-
-
4
BAP1-related tumor predisposition syndrome (4)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
1
BAP1-related tumor predisposition syndrome;C5676925:Kury-Isidor syndrome (1)
-
-
1
Melanoma, uveal, susceptibility to, 2 (1)
-
-
1
Melanoma, uveal, susceptibility to, 2;C3280492:BAP1-related tumor predisposition syndrome;C5676925:Kury-Isidor syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.6
DANN
Benign
0.77
PhyloP100
-0.16
PromoterAI
-0.013
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00017
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150945583; hg19: chr3-52437424; API